Literature DB >> 20181794

Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation.

Chun-Rong Chen1, Sandra M McLachlan, Basil Rapoport.   

Abstract

The TSH receptor (TSHR) ectodomain comprises a tubular leucine-rich repeat domain (LRD) and a hinge [or signaling specificity domain (SSD)]. TSH binds to both the LRD and SSD, leading to signal transduction by the transmembrane domain. The SSD structure and spatial orientation to the other components are unknown. We exploited a fortuitous observation to obtain mechanistic insight into the relationship between TSH binding and signal transduction. A mouse TSHR cDNA generated by PCR was found to express a receptor with poor TSH-induced cAMP generation despite normal TSH binding. Progressive reversion to wild-type of six mutations revealed E251K in the LRD to be critical for reduced signal transduction in both mouse and human TSHR. An I286F substitution in the SSD had a much weaker effect and was additive with E251K. To our knowledge, there are no previous examples of specific amino acid mutations in the TSHR LRD that dissociate TSH binding from TSHR signal transduction. To prevent flailing of the TSHR LRD, its position vis-à-vis the SSD must be stabilized by multiple amino acid interactions. The present data suggest that TSHR residue E251 is one of these residues involved in stabilizing the LRD relative to the SSD, thereby enabling ligand binding to transduce a signal by the latter. That the E251K mutation can reduce signal transduction despite high-affinity TSH binding comparable with the wild-type TSHR provides mechanistic insight into the coupling between ligand binding and receptor activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181794      PMCID: PMC2851189          DOI: 10.1210/en.2009-1430

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  44 in total

1.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

Review 2.  Somatic and germline mutations of the TSH receptor and thyroid diseases.

Authors:  B Corvilain; J Van Sande; J E Dumont; G Vassart
Journal:  Clin Endocrinol (Oxf)       Date:  2001-08       Impact factor: 3.478

3.  Model of glycoprotein hormone receptor ligand binding and signaling.

Authors:  William R Moyle; Yongna Xing; Win Lin; Donghui Cao; Rebecca V Myers; John E Kerrigan; Michael P Bernard
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

4.  Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.

Authors:  Y Nagayama; K D Kaufman; P Seto; B Rapoport
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

5.  Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.

Authors:  S Costagliola; V Panneels; M Bonomi; J Koch; M C Many; G Smits; G Vassart
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

6.  Autoregulation of the thyroid. Response to iodide excess and depletion.

Authors:  S H Ingbar
Journal:  Mayo Clin Proc       Date:  1972-11       Impact factor: 7.616

7.  A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

Review 8.  A molecular dissection of the glycoprotein hormone receptors.

Authors:  Gilbert Vassart; Leonardo Pardo; Sabine Costagliola
Journal:  Trends Biochem Sci       Date:  2004-03       Impact factor: 13.807

9.  Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity.

Authors:  Guillaume Smits; Mercedes Campillo; Cédric Govaerts; Véronique Janssens; Christine Richter; Gilbert Vassart; Leonardo Pardo; Sabine Costagliola
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

Authors:  Y Nagayama; H L Wadsworth; G D Chazenbalk; D Russo; P Seto; B Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  10 in total

1.  TSH receptor extracellular region mutations in thyroid functioning nodules: further evidence for the functional role of this region in the receptor activation.

Authors:  D Russo; G Costante; R Bruno; M Sponziello; G Tamburrano; M Dima; R Sacco; L Giacomelli; C Durante; S Filetti
Journal:  Endocrine       Date:  2011-08-24       Impact factor: 3.633

2.  Relationship between thyrotropin receptor hinge region proteolytic posttranslational modification and receptor physiological function.

Authors:  Sepehr Hamidi; Chun-Rong Chen; Yumiko Mizutori-Sasai; Sandra M McLachlan; Basil Rapoport
Journal:  Mol Endocrinol       Date:  2010-11-24

3.  Defining structural and functional dimensions of the extracellular thyrotropin receptor region.

Authors:  Gunnar Kleinau; Sandra Mueller; Holger Jaeschke; Paul Grzesik; Susanne Neumann; Anne Diehl; Ralf Paschke; Gerd Krause
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

4.  The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.

Authors:  Chun-Rong Chen; Larry M Salazar; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2012-10       Impact factor: 4.736

5.  Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.

Authors:  A Schlüter; M Horstmann; S Diaz-Cano; S Plöhn; K Stähr; S Mattheis; M Oeverhaus; S Lang; U Flögel; U Berchner-Pfannschmidt; A Eckstein; J P Banga
Journal:  Clin Exp Immunol       Date:  2017-11-17       Impact factor: 4.330

6.  Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor.

Authors:  Chun-Rong Chen; Larry M Salazar; Sandra M McLachlan; Basil Rapoport
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

7.  Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor.

Authors:  Jörg Schaarschmidt; Sandra Huth; René Meier; Ralf Paschke; Holger Jaeschke
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

Review 8.  Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.

Authors:  Gunnar Kleinau; Catherine L Worth; Annika Kreuchwig; Heike Biebermann; Patrick Marcinkowski; Patrick Scheerer; Gerd Krause
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

9.  The hinge region of human thyroid-stimulating hormone (TSH) receptor operates as a tunable switch between hormone binding and receptor activation.

Authors:  Ritankar Majumdar; Rajan R Dighe
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Graves' orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model.

Authors:  Anke Schlüter; Ulrich Flögel; Salvador Diaz-Cano; Gina-Eva Görtz; Kerstin Stähr; Michael Oeverhaus; Svenja Plöhn; Stefan Mattheis; Lars C Moeller; Stephan Lang; Nikolaos E Bechrakis; J Paul Banga; Anja Eckstein; Utta Berchner-Pfannschmidt
Journal:  Sci Rep       Date:  2018-08-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.